NEW YORK (GenomeWeb) – FlowMetric today announced the formation of an affiliate company, FlowMetric Diagnostics, to leverage flow cytometry technology in the development of companion diagnostics.
Doylestown, Penn.-based FlowMetric is a contract research organization that provides polychromatic flow cytometry and cell sorting services to the biopharma and drug discovery market. FlowMetric Diagnostics plans to establish a US Food and Drug Administration-compliant flow cytometry laboratory in order to run CLIA-certified diagnostic tests from its own assay portfolio and from partnering diagnostic companies.
The creation of the new firm "represents the natural progression of the FlowMetric business into the clinical marketplace and recognizes the need for additional diagnostics," FlowMetric CEO Ren Capocasale said in a statement.
Amy Williams will serve as FlowMetric Diagnostics' president, while Julie Bick will be its CSO. Capocasale will be the company's chairman.